@article{e4df99d3ccd74f64a4c8b0cde5106aee,
title = "Xenograft-directed personalized therapy for a patient with post-transplant relapse of ALL",
author = "Trahair, \{T. N.\} and Lock, \{R. B.\} and R. Sutton and Sia, \{K. C S\} and K. Evans and J. Richmond and T. Law and Venn, \{N. C.\} and Irving, \{J. A.\} and S. Moore and E. Nievergall and P. Dang and Heatley, \{S. L.\} and White, \{D. L.\} and T. Revesz",
note = "Funding Information: This research was funded by the Children's Cancer Institute and grants from the National Cancer Institute (NOI-CM-42216 and NOI-CM-91001-03) and National Health and Medical Research Council of Australia (NHMRCAPP1024232 and APP1044884). RBL is supported by an NHMRC Fellowship (1059804). We acknowledge funding from the Sporting Chance Cancer Foundation (RS), Leukaemia and Lymphoma Research UK (JAI). Children's Cancer Institute Australia is affiliated with UNSW Australia and the Sydney Children's Hospitals Network. SAR3419 was provided by Sanofi through the Cancer Therapy Evaluation Program, NCI.",
year = "2016",
month = sep,
day = "1",
doi = "10.1038/bmt.2016.122",
language = "English",
volume = "51",
pages = "1279--1282",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
number = "9",
}